JNJ
🟢 JNJ is trading 3.5% up today, driven by positive clinical trial results and a significant investment
• Shares are currently trading at $268.46, up 3.5%, rebounding sharply from the prior session’s decline.
• Johnson & Johnson highlighted positive primary...